Navigation Links
Optimer Pharmaceuticals Reports Second Quarter 2011 Financial Results
Date:8/4/2011

$
(0.52)$
(0.26)$
.47$
(0.64)Net income (loss) per share - diluted

$
(0.52)$
(0.26)$
.46$
(0.64)Weighted average number of shares used to compute net  income (loss) per share - basic

46,479,39538,306,91044,581,01036,663,380Weighted average number of shares used to compute net  income (loss) per share - diluted

46,479,39538,306,91045,447,26136,663,380Optimer Pharmaceuticals, Inc.Condensed Consolidated Balance SheetsJune 30December 31,20112010(unaudited)ASSETSCurrent assets:Cash and cash equivalents

$   61,402,529$   19,861,924Short-term investments

96,391,74229,553,506Research grant and other  receivables

78,95753,552Inventory

1,369,482-Prepaid expenses and other current assets

5,843,511463,307Total current assets

165,086,22149,932,289Property and equipment, net

2,172,443697,683Long-term investments

882,000882,000Other assets

1,242,523508,190Total assets

$ 169,383,187$   52,020,162LIABILITIES  AND STOCKHOLDERS' EQUITY Current liabilities:Accounts payable

$
,738,492$
2,307,820Accrued expenses

5,080,6792,385,046Total current liabilities

11,819,1714,692,866Deferred rent

183,515141,138Stockholders’ equity

157,380,50147,186,158Total liabilities and stockholders’ equity

$ 169,383,187$   52,020,162
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Optimer Launches DIFICID™ (fidaxomicin) Tablets for Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) in Patients 18 Years of Age and Older
2. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3. Optimer Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
4. Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results
5. Optimer Pharmaceuticals Expands Senior Management Team
6. Optimer Pharmaceuticals to Present at May 2011 Investor Conferences
7. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
8. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
9. Trading Halted Today in Optimer Pharmaceuticals Stock
10. Optimer Pharmaceuticals Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile Infection (CDI) in Hospital Patients
11. Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... CHICAGO , Sept. 23, 2014  Hill-Rom (NYSE: ... agreement with Providence Health ( Renton, WA ... new agreement expands the companies, existing relationship as Hill-Rom ... Maternal, and Bariatric capital bed frame and surface products. ... largest health systems in the U.S.  It operates 34 ...
(Date:9/23/2014)... , Sept. 23, 2014 Research ... "Biopharmaceutical and Vaccine Production Markets" report to ... many new therapies and vaccines - including products to ... are still huge challenges during the final stages of ... when and how to risk production capital to upscale ...
(Date:9/23/2014)... 23, 2014 Rising health ... and increasing number of foreign and domestic players in ... India   The ... most high growth potential markets worldwide due to multiple ... among the youth, changing food consumption patterns, increasing diabetic ...
Breaking Medicine Technology:Hill-Rom Announces Seven-Year, Sole-Source Contract with Providence Health 2Biopharmaceutical and Vaccine Production Markets 2Biopharmaceutical and Vaccine Production Markets 3India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 2India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 3
... 10th Annual Superbugs and Superdrugs Conference on ... ... 10 Enanta Pharmaceuticals, a,leader in the development of small ... program to,evaluate a new macrolide-related drug class, Bicyclolides, in the ...
... - Strategic Collaboration with the National Cancer Institute,s NABTT ... ... 10 BiPar Sciences, Inc. today,announced the expansion of the clinical ... the most,common glioma in adults. BSI-201, the first poly ADP-ribose polymerase,(PARP) ...
Cached Medicine Technology:Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA 2Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA 3BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer 2
(Date:9/23/2014)... Swedish study shows that adolescents who suffer from sleep ... to succeed academically compared to those who enjoy a ... in the journal Sleep Medicine . , In ... between 12 and 19 from Uppsala County, researchers from ... habitual short sleep duration (less than 7 hours per ...
(Date:9/23/2014)... San Jose, California (PRWEB) September 23, 2014 ... – Medical transcription is the process of translating ... assessment, clinical course, therapeutic procedures, and prognosis, into ... health insurance agents, patients, and healthcare providers. With ... documentation of each patient’s condition, outsourcing of such ...
(Date:9/23/2014)... If you or a loved one ... treatment may be a challenge. Fortunately, an inventor from ... is designed to improve the experience. , He developed ... having to remove, tear or reposition their clothing. Furthermore, ... their dignity. At the same time, it safeguards their ...
(Date:9/23/2014)... be able to grow enough food there to maintain ... food in NASA,s Orion spacecraft on the year-long trip ... extreme conditions? These are questions scientists are trying to ... International Space Station (ISS). , Plant biology investigations called ... to adapt to a microgravity environment. When a crew ...
(Date:9/23/2014)... allow electrical signals to pass unhindered through new ... Texas Children,s Hospital. , A team led by ... Matteo Pasquali created the patches infused with conductive ... a sponge-like bioscaffold that contains microscopic pores and ... overcome a limitation of current patches in which ...
Breaking Medicine News(10 mins):Health News:Expanding Healthcare Sector Drives Demand for Medical Transcription Services, According to New Report by Global Industry Analysts, Inc. 2Health News:Expanding Healthcare Sector Drives Demand for Medical Transcription Services, According to New Report by Global Industry Analysts, Inc. 3Health News:Apparel for Dialysis Patients Invented by InventHelp Client (CBA-2492) 2Health News:Getting to the root of the problem in space 2Health News:Getting to the root of the problem in space 3Health News:Getting to the root of the problem in space 4Health News:Nanotubes help healing hearts keep the beat 2Health News:Nanotubes help healing hearts keep the beat 3
... revolutionary EnviroCool fresh air cooling system also ... air pollution, WINCHESTER, Calif., June 11 With ... on the rise, homeowners around the,country are turning to ... cool their homes: QuietCool and EnviroCool., The QuietCool ...
... HMS Holdings Corp. (Nasdaq:,HMSY) today announced that it will ... held June 24-26, 2008 in New York,City., Walter ... Corp.,will present on Tuesday, June 24th at 10:15 am ... presentation can be accessed through,our website at http://www.hmsholdings.com/news/presentations.asp ...
... Research Group, offering hope to sufferers of asbestos-related ... today. , Special guest Karen Banton, widow of ... the group, saying: , "Today brings hope of ... asbestos exposure and ultimately a future free of ...
... Award Presented to QualityMetric Employee at Annual ... ... 11 In recognition of clinical,research to improve the understanding ... Senior Scientist with,QualityMetric(TM) Health Outcomes Solutions, was presented the 2008-2009,American ...
... Patient Share by 2012, According to a ... New Report from Decision Resources, ... the,world,s leading research and advisory firms focusing on pharmaceutical and,healthcare ... of,fistulas in a greater percentage of patients than,Centocor/Schering-Plough/Mitsubishi Tanabe,s Remicade ...
... in children may have an impact on cardiovascular functioning ... according to a research abstract that will be presented ... the Associated Professional Sleep Societies (APSS). , The study, ... of Melbourne and Monash University, Melbourne, Victoria, Australia, focused ...
Cached Medicine News:Health News:A Far Less Expensive, Green Alternative to Traditional Air Conditioning, from QuietCool 2Health News:New research group offers hope to asbestosis sufferers 2Health News:New research group offers hope to asbestosis sufferers 3Health News:QualityMetric Senior Scientist Min Yang, MD, PhD, Recipient of Prestigious Clinical Research Award in Women's Health 2Health News:QualityMetric Senior Scientist Min Yang, MD, PhD, Recipient of Prestigious Clinical Research Award in Women's Health 3Health News:A Drug With Efficacy Superior to That of Remicade at Inducing Closure and Healing of Fistulas Would Earn a 30 Percent Patient Share in the Crohn's Disease Drug Market 2Health News:Primary snoring in children impacts cardiovascular functioning 2Health News:Primary snoring in children impacts cardiovascular functioning 3
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures....
Thermal Cautery, Sterile Single-Use Units for Vasectomy. Burns at approximately 1200C (2200 F). Integrated unit includes handle, vasectomy tip, & AA batteries. Box of 10 units. Discounts on 2 or more...
Non-Cantilevered Ringed Forceps. ("fixation clamp") For vasectomy and other procedures. Ring diameter approximately 3.0 mm....
... earmolds add comfort and enhance hearing abilities ... paramedics, Flight-for-Life helicopter personnel, emergency technicians and ... specific in design and can be fabricated ... in today's industry to ensure clear sound ...
Medicine Products: